1 Leonhardt H, "Studies of plasma viscosity in primary hyperlipoproteinaemia" 28 : 29-40, 1977
2 Rosenson RS, "Hypertriglyceridemia is associated with an elevated blood viscosity rosenson: triglycerides and blood viscosity" 161 : 433-439, 2002
3 Rosenson RS, "Hypertriglyceridemia and other factors associated with plasma viscosity" 110 : 488-492, 2001
4 Simpson HC, "Hypertriglyceridaemia and hypercoagulability" 1 : 786-790, 1983
5 Yarnell JW, "Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The caerphilly and speedwell collaborative heart disease studies" 83 : 836-844, 1991
6 Sweetnam PM, "Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease" 17 : 1814-1820, 1996
7 Humphries SE, "Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration" 14 : 193-198, 1994
8 Irish AB, "Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype" 13 : 679-684, 1998
9 Seplowitz AH, "Effects of lipoproteins on plasma viscosity" 38 : 89-95, 1981
10 Feussner G, "Clinical features of type III hyperlipoproteinemia: analysis of 64 patients" 71 : 362-366, 1993
1 Leonhardt H, "Studies of plasma viscosity in primary hyperlipoproteinaemia" 28 : 29-40, 1977
2 Rosenson RS, "Hypertriglyceridemia is associated with an elevated blood viscosity rosenson: triglycerides and blood viscosity" 161 : 433-439, 2002
3 Rosenson RS, "Hypertriglyceridemia and other factors associated with plasma viscosity" 110 : 488-492, 2001
4 Simpson HC, "Hypertriglyceridaemia and hypercoagulability" 1 : 786-790, 1983
5 Yarnell JW, "Fibrinogen, viscosity, and white blood cell count are major risk factors for ischemic heart disease. The caerphilly and speedwell collaborative heart disease studies" 83 : 836-844, 1991
6 Sweetnam PM, "Fibrinogen, viscosity and the 10-year incidence of ischaemic heart disease" 17 : 1814-1820, 1996
7 Humphries SE, "Factor VII coagulant activity and antigen levels in healthy men are determined by interaction between factor VII genotype and plasma triglyceride concentration" 14 : 193-198, 1994
8 Irish AB, "Factor VII coagulant activity (VIIc) and hypercoagulability in chronic renal disease and dialysis: relationship with dyslipidaemia, inflammation, and factor VII genotype" 13 : 679-684, 1998
9 Seplowitz AH, "Effects of lipoproteins on plasma viscosity" 38 : 89-95, 1981
10 Feussner G, "Clinical features of type III hyperlipoproteinemia: analysis of 64 patients" 71 : 362-366, 1993
11 Julia Lewis BG, "Atheromatous and thromboembolic renovascular disease. Comprehensive Clinical Nephrology 3rd edition" 741-734, 2007